Semaglutide, available under the brand names Ozempic and Wegovy, may help decrease the risk of major adverse cardiovascular ...

Discover how semaglutide reduces heart attack and stroke risk by 20% in overweight individuals, with benefits appearing ...

Among patients who experienced an early cardiovascular event, those treated with semaglutide had approximately 40% fewer ...

The weight-loss drug Wegovy slashes the risk of heart disease even before people shed many pounds, data suggests. The drug, which contains the active ingredient semaglutide, works by reducing food ...

Researchers have found in a new study that semaglutide could provide cardiovascular benefits to high-risk patients even ...

Limited effectiveness, weight regain, and high prevalence of adverse events are the three key limitations of semaglutide ...

Landmark' data has revealed a popular weight loss medicine slashes the risk of heart attack, stroke or heart disease death ...

The SELECT trial, first conducted in 2023, demonstrated that semaglutide could reduce the risk of major heart events—such as ...

A new study has found that a drug called semaglutide could help improve heart health in people who are overweight or obese, ...

New data suggests the weight-loss drug Wegovy may significantly reduce the risk of heart disease even before users experience ...

An international study reveals that the drug can reverse liver damage in patients. An international study led by researchers ...

What is the difference between prediabetes and diabetes, and which do I have? I am male, 85 years old, 170 pounds, and 6 feet ...